Amadea Britton

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

Emma K. Accorsi, Amadea Britton, Katherine E. Fleming-Dutra et al. · JAMA · 2022 · 677 citations · Full text

Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

Miwako Kobayashi, Jennifer L. Farrar, Ryan Gierke et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 326 citations · Full text

Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

Michael Melgar, Amadea Britton, Lauren E. Roper et al. · MMWR Morbidity and Mortality Weekly Report · 2023 · 293 citations · Full text

Respiratory Virus Immunity, Immunology, Respiratory Complications +22

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022

Ruth Link‐Gelles, Allison Avrich Ciesla, Katherine E. Fleming-Dutra et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 185 citations · Full text

Booster Formulation, Immunodeficiencies, Immunology +19

Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance

Katherine E. Fleming-Dutra, Amadea Britton, Nong Shang et al. · JAMA · 2022 · 159 citations · Full text